Skip to main content
Veterinary Medicines

NAFPENZAL ASCIUTTA

Authorised
  • Dihydrostreptomycin
  • Nafcillin
  • Benzylpenicillin procaine

Product identification

Medicine name:
NAFPENZAL ASCIUTTA
Active substance:
  • Dihydrostreptomycin
  • Nafcillin
  • Benzylpenicillin procaine
Target species:
  • Cattle
  • Sheep
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Dihydrostreptomycin
    100.00
    milligram(s)
    /
    1.00
    Syringe
  • Nafcillin
    100.00
    milligram(s)
    /
    1.00
    Syringe
  • Benzylpenicillin procaine
    300.00
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary ointment
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Meat and offal
        16
        day
      • Milk
        48
        hour
    • Sheep
      • Meat and offal
        35
        day
      • Milk
        108
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RC22
Authorisation status:
  • Valid
Authorised in:
This information is not available for this product.
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 3/06/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."